CAS 1255502-07-8

R-MVA-Li

Description:

R-MVA-Li, identified by the CAS number 1255502-07-8, is a lithium salt of a specific derivative of malonic acid, which is often used in various chemical applications, including organic synthesis and materials science. This compound typically exhibits characteristics common to lithium salts, such as high solubility in polar solvents and the ability to participate in ionic interactions. R-MVA-Li may also demonstrate unique reactivity due to the presence of functional groups derived from malonic acid, which can facilitate various chemical transformations. Its structure likely includes a lithium ion coordinated with a malonate moiety, contributing to its stability and reactivity profile. The compound's properties, such as melting point, boiling point, and specific reactivity, would depend on its molecular structure and the nature of the substituents attached to the malonate framework. Overall, R-MVA-Li is of interest in research and industrial applications, particularly in fields that explore lithium-based materials and their derivatives.

Formula: C₆H₁₃LiO₄

Synonyms:

• Lithium (R)-3,5-dihydroxy-3-methylpentanoate
• Lithium (R)-3,5-dihydroxy-3-methylvalerate
• (R)-Mevalonic acid lithium salt
• R-MVA-Li
• (R)-Mevalonic acid lithium salt >=93.0% (qNMR)

Lithium (R)-3,5-dihydroxy-3-methylpentanoate

CAS: 1255502-07-8

Purity: ≥93%

Color and Shape: Liquid

Ref: BD-BD01217637

LITHIUM (R)-3,5-DIHYDROXY-3-METHYLPENTANOATE

CAS: 1255502-07-8

Formula: C₆H₁₁LiO₄

Purity: 93.0%

Molecular weight: 154.0901

Ref: IN-DA01FL1Y

(R)-Mevalonic acid lithium

CAS: 1255502-07-8

(R)-Mevalonic acid lithium is a diterpene that is derived from mevalonic acid. It has been shown to have regulatory effects on T cells in the intestines, which may be due to its ability to induce the production of Th17 cells. (R)-Mevalonic acid lithium has been shown to inhibit the transfer of prenyl groups from farnesyl pyrophosphate and geranylgeranyl pyrophosphate onto the protein prenyltransferase, inhibiting growth factor activity. This drug also inhibits dextran sulfate-induced colitis by mechanisms that are not yet known. (R)-Mevalonic acid lithium is metabolized by cytochrome P450 enzymes and can form reactive oxygen species as byproducts, which may account for its anti-inflammatory properties.

Formula: C₆H₁₂O₄•Li

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 155.1 g/mol

Ref: 3D-FAC50207